There are 352 resources available
Welcome to the Congress
Presenter: Luis Paz-Ares
Session: Opening and welcome
Resources:
Slides
Webcast
Introduction to ESMO
Presenter: Solange Peters
Session: Opening and welcome
Resources:
Slides
Webcast
Introduction to IASLC
Presenter: Giorgio Scagliotti
Session: Opening and welcome
2018 HHH Award Winner Introduction
Presenter: Solange Peters
Session: Opening and welcome
Resources:
Slides
Webcast
HHH Award Keynote Lecture: The power of the multiple H
Presenter: Fabrice Barlesi
Session: HHH Award Keynote Lecture
Resources:
Slides
Webcast
Is PFS still a relevant endpoint for first-line TKIs?
Presenter: Suresh Ramalingam
Session: First line for oncogene addicted lung cancer
Resources:
Slides
Webcast
First vs second vs third generation EGFR TKI
Presenter: Juergen Wolf
Session: First line for oncogene addicted lung cancer
Resources:
Slides
Webcast
Key factors that determine the selection of first-line ALK inhibtiors
Presenter: Fiona Blackhall
Session: First line for oncogene addicted lung cancer
Resources:
Slides
Webcast
The role of first-line combination therapy for oncogene addicted lung cancer
Presenter: Takashi Seto
Session: First line for oncogene addicted lung cancer
Resources:
Slides
Webcast
When concurrent chemo-radiotherapy is not the preferred choice
Presenter: Pierre Fournel
Session: Combined treatment stage III
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.